CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 6,911 shares at $90.27 ($623,853)
- 4 Planned sale Director sold 2,000 shares at $90.99 ($181,980)
- 4 Gift CHIEF EXECUTIVE OFFICER gave 21,070 shares (gift)
- 4 Planned sale Director sold 5,000 shares at $80.00 ($400,000)
- 4 Planned sale Director sold 50,000 shares at $78.00 ($3,900,000)
- 4 Planned sale Director sold 2,000 shares at an average $69.73 ($139,460)
- 4 Planned sale Director sold 50,000 shares at $74.00 ($3,700,000)
- 4 Planned sale Director sold 50,000 shares at $70.00 ($3,500,000)
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 19,133 shares (option exercise)
- 4 Open-market sale Director sold 17,000 shares at an average $74.40 ($1,264,868)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 9,578 shares at $76.01 ($728,024)
- 4 Open-market sale Director sold 17,000 shares
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 8,000 shares
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 40,000 shares at $62.00 ($2,480,000)
- 4 Planned sale SVP, GLOBAL CONTROLLER sold 10,000 shares at $58.00 ($580,000)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 40,000 shares at $55.25 ($2,210,040)
- 4 Planned sale SVP, GLOBAL CONTROLLER sold 1,041 shares at an average $48.63 ($50,624)
- 4 Open-market sale Director sold 3,203 shares at $48.42 ($155,091)
- 4 Open-market sale Director sold 8,203 shares at an average $46.06 ($377,843)
- 4 Option exercise Director acquired 5,703 shares (option exercise)
Page 4 of 18 · 355 filings